Bristol Myers Squibb

Leader

Company Overview

Bristol Myers Squibb Company is an American multinational pharmaceutical powerhouse headquartered in Princeton, New Jersey, with a rich heritage dating back to the 1800s. The company resulted from the landmark 1989 merger of Bristol-Myers and Squibb, combining two pharmaceutical pioneers into what was then the second-largest pharmaceutical company in the world. Today, BMS stands as a global leader in biopharmaceuticals with a market capitalization exceeding $106 billion and annual revenues of $48.3 billion as of 2024.

The company's strategic focus centers on four key therapeutic areas: oncology, cardiovascular disease, immunology, and hematology. BMS has built an impressive portfolio of blockbuster drugs, with its blood thinner Eliquis generating $13.3 billion in annual revenue (28% of total revenues), cancer immunotherapy Opdivo contributing $9.2 billion (19% of revenues), and multiple myeloma treatment Revlimid adding $5.8 billion (12% of revenues). The company's aggressive acquisition strategy has strengthened its pipeline, with major 2024 acquisitions including Karuna Therapeutics for $14 billion, Mirati Therapeutics for $4.8 billion, and RayzeBio for $4.1 billion.

Bristol Myers Squibb operates a global footprint with approximately 34,000 employees across research facilities in Princeton, Cambridge (Massachusetts), Redwood City (California), and international locations including Boudry (Switzerland), Seville (Spain), Bangalore (India), and Tokyo (Japan). The company's "Growth Portfolio" of newer products generated $22.6 billion in 2024, growing 17% year-over-year, led by breakthrough therapies like Cobenfy (the first novel schizophrenia treatment in 70 years), CAR-T cell therapies Breyanzi and Abecma, and immunotherapy Opdualag. Under the leadership of CEO Dr. Christopher Boerner, who assumed the role in November 2023, BMS continues to invest heavily in research and development while navigating patent cliffs for key products through innovation and strategic dealmaking.

The company's commitment to patients extends beyond medicines to encompass workplace culture, with BMS recognized for military-friendly employment, age-inclusive practices, and comprehensive benefits valued at over $9,400 per employee. With a mission to help patients prevail over serious diseases, Bristol Myers Squibb combines scientific excellence, strategic vision, and global scale to address some of healthcare's most challenging conditions.

Founded
1887
Headquarters
Clinton, New York

The Bristol Myers Squibb Story

Founded in 1887
Clinton, New York
Founded by William McLaren Bristol, John Ripley Myers

Founders

William McLaren BristolJohn Ripley Myers
Loading News...
Loading Timeline...
Loading Culture...
Loading Leadership...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Market Leader

Bristol Myers Squibb is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.

Frequently Asked Questions

AI Visibility Rankings

How Bristol Myers Squibb performs in AI search results

AI Rank
?
Track your position
Platforms
5
ChatGPT, Gemini, Claude...
Visibility
?
Your mention rate
Premium Feature

Unlock AI Visibility Tracking for Bristol Myers Squibb

See exactly how Bristol Myers Squibb ranks across ChatGPT, Gemini, Perplexity, Claude, and Grok. Get actionable insights to improve your AI search performance.

Real-time Rankings
Track your position daily
Competitive Intel
See how you compare
Platform Breakdown
Per-AI performance
Actionable Insights
Optimize your visibility
Start Tracking for Free

Join 1,000+ brands · Free 7-day trial · No credit card required

Want to improve your AI visibility? Track performance across all major AI platforms.
Compare with Other Brands

Not So Random Others

Compare with Other Brands

See how Bristol Myers Squibb stacks up against competitors with our detailed comparison tool.

Start Comparison